The Africa Clinical Research Network (ACRN) has started its first clinical trial using Oracle's cloud-based safety and analytics solutions to study pre-eclampsia in African women. The PROTECT-Africa trial, running in Zimbabwe, Rwanda, and Tanzania, aims to validate biomarkers that predict severe pregnancy complications, recruiting over 1,100 participants. This initiative addresses the low representation of Africa in global clinical trials and seeks to build a sustainable research ecosystem across 14 African countries. By leveraging Oracle's technology, ACRN aims to enhance trial efficiency, patient safety, and accelerate access to relevant medical innovations for African populations.
The AI-driven stock rally in 2026, initially led by semiconductor companies, is expanding to cloud infrastructure, cybersecurity, and software sectors. ETFs like First Trust Cloud Computing (SKYY), First Trust Nasdaq Cybersecurity (CIBR), and iShares...
Yields on bonds climbed this week after Alphabet increased its capital expenditure forecast for AI development, sparking fears that other major tech companies like Amazon and Meta will follow. Fixed-income investors are demanding higher credit spread...
Leading AI-focused tech giants like Alphabet, Meta, Amazon, Oracle, and Microsoft have seen their stock prices decline since April 2023, with Oracle dropping over 31%. The main reason is soaring capital expenditure (capex) on AI development, which is...
Moody's warns that the massive investment in AI infrastructure by tech giants like Alphabet, Microsoft, Amazon, and Meta is eroding their free cash flow and increasing balance-sheet risks. These companies are shifting from asset-light to asset-heavy ...
Oracle is currently investing heavily in data centers and AI, which has led to temporary negative free cash flow and borrowing. Despite market skepticism, these moves are typical for companies building physical assets and focusing on data, Oracle's c...
